科研之友
微信
新浪微博
Facebook
分享链接
摘要
In this issue of Blood, Liyanage et al demonstrate that acute myeloid leukemia (AML) cells exhibit increased mitochondrial DNA (mtDNA) content and that the 2',3'-dideoxycytidine (ddC; an inhibitor of mtDNA biosynthesis already used in clinic) selectively kills leukemia cells.(1)
- 出版日期2017-5-11
